Ambulatory Coronary Angiography: Is any further evidence required?

Original title: Same-Day Discharge Compared With Overnight Hospitalization After Uncomplicated Percutaneous Coronary Intervention. A Systematic Review and Meta-Analysis Reference: Eltigani Abdelaal et al. J Am Coll Cardiol Intv 2013. Article in press.

Coronary angioplasty and subsequent same day discharge in selected patients can reduce costs and increase patient comfort. 

Several observational studies and a few randomized studies have described the safety of same day discharge, however, opinions still vary extensively among the different centers. In an attempt to answer these questions, a meta analysis was carried out to evaluate the total incidence of complications, major cardiovascular events (MACE) and rehospitalization at 30 days.

13 studies were analyzed (5 randomized and 8 observational) with a total of 111830 patients. 96% of procedures were approach by femoral access and 83% of patients were discharged the same day. The median permanence time of same day discharged patients was 4 to 8 hrs.

In randomized studies there were no significant differences in the total number of complications between same day discharged patients and those patients that remained hospitalized (6.5% vs. 5.5% respectively; OR:1.2, 95% IC:0.82 -1.01). At 30 days, MACE incidence in randomized studies was identical in both groups (1.3%), rehospitalizations show no differences as well (4% vs. 3.6%; OR 1.1, 95%IC: 0.7-1.7). Observational studies reached similar conclusions in all the above mentioned.

Conclusion:

The heterogeneous nature of these studies call for a randomized study to assess the correct strategy. Until then, same day discharge after non complicated angioplasty is reasonable in selected patients.

Editorial Comment: 

The randomized study that in theory would be necessary to reach a definite valid conclusion should include more than 17,000 patients to reach enough statistic power seeing the low frequency of these events. It is highly unlikely that we will count on this information in a near future, if ever available. Even though the use of the radial artery is less than 5%, if we exclude the analysis of observational studies performed in the USA (Rao et al., among others) the radial approach reaches almost 50% of cases, which speaks for the low preference of this approach in this country. Seeing the main reasons behind same day discharge are cost reduction and patient comfort, the radial approach seems the most sensible choice.

SOLACI.ORG

More articles by this author

ACC 2026 | DKCRUSH VIII: IVUS or angiography to guide PCI in complex coronary bifurcations

Intracoronary imaging guidance has become an established recommended strategy in complex coronary lesions. In the specific setting of complex bifurcations, uncertainty remained regarding the...

ACC 2026 | OPTIMAL: IVUS Guidance in PCI of the Unprotected Left Main Coronary Artery

Percutaneous coronary intervention (PCI) is considered an equivalent alternative to coronary artery bypass surgery in patients with left main coronary artery (LMCA) stenosis and...

ACC 2026 | IVUS-CHIP Trial: Intravascular ultrasound–guided versus angiography-guided complex PCI

Optimization of percutaneous coronary intervention (PCI) in complex lesions remains a relevant clinical challenge. In this context, the IVUS-CHIP trial was designed to evaluate...

ACC 2026 | ALL-RISE Trial: Coronary Physiological Assessment Using FFRangio

Coronary physiological assessment using pressure-wire techniques (FFR/iFR) carries a Class IA recommendation in ACC/AHA guidelines; however, its use remains limited due to factors such...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the forefront as a clinically...

Experience with the intra-annular self-expanding Navitor valve: data from the STS/ACC TVT registry

The expansion of TAVI, with the introduction of new-generation devices, has prioritized not only periprocedural safety, but also the preservation of coronary access, more...

Therapeutic strategies in carotid free-floating thrombus: evidence and controversies

Carotid free-floating thrombus (cFFT) is a rare entity with a high embolic risk, associated with acute neurological events such as stroke or transient ischemic...